Adjuvanted RSVPreF3 vaccine effectiveness against RSV-related hospitalization among US adults ≥60 years

IF 2.9 3区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Australian and New Zealand Journal of Public Health Pub Date : 2026-01-01 Epub Date: 2026-06-13 DOI:10.1016/j.anzjph.2026.100356

David Singer , Andrea Steffens , Elizabeth La , Emily K. Horn , Katherine Theiss-Nyland , Maria João Fonseca , Dr Agnes Chaumont , Susan Gerber , Alison Kawai , Ami Buikema , Mary G. Johnson , Rui Song , Sarah Hague , J. Bradley Layton

引用次数: 0

查看原文本刊更多论文

佐剂RSVPreF3疫苗在美国≥60岁成人中预防rsv相关住院的有效性

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Australian and New Zealand Journal of Public Health 医学-公共卫生、环境卫生与职业卫生

CiteScore

4.20

自引率

5.70%

发文量

121

审稿时长

6-12 weeks

期刊介绍： The Australian and New Zealand Journal of Public Health (ANZJPH) is concerned with public health issues. The research reported includes formal epidemiological inquiries into the correlates and causes of diseases and health-related behaviour, analyses of public policy affecting health and disease, and detailed studies of the cultures and social structures within which health and illness exist. The Journal is multidisciplinary and aims to publish methodologically sound research from any of the academic disciplines that constitute public health.